Friday, 10 April 2026
  
Login

Australia's most trusted
source of pharma news

Friday, 10 April 2026
News

Multiple roadblocks for IBD drugs

Posted 9 April 2026 AM

There is a disease that causes more interactions with Australia's health system than all cancers combined, but the government is dragging its feet on funding cures.

March marked a full year since Crohn's & Colitis Australia (CCA) released its IBD State of the Nation Report, and CCA hosted a parliamentary event bringing together key inflammatory bowel disease (IBD) stakeholders to explore the future of IBD care in Australia.

To see the whole article, please login

Popular

Trump tariffs unleash hidden chaos
What Chat says about your drugs
Four brands hit with price cuts
Marketers 'not quite up to notch'
Latest Jobs
Pharma in Focus  Jobs
MORE NEWS
Email this article to a friend
From:

 
 
  
Print this article

Copyright Notice

Please click the button to indicate that the printout of this article is for your personal use only and not for any type of redistribution.

Redistribution of the whole or part of Pharma in Focus by any means is a breach of copyright law.

Welcome to Pharma in Focus

Please log in to read.

Hi

Our old access system is being retired.

Please create a password and click 'Log in' for ongoing access.

Hi

Please choose a password to secure your access to Pharma in Focus (minimum 8 characters).

Hi

You're here because you requested to reset your password.

Please choose a new password (minimum 8 characters).

To search the News Archive you need to be logged in.

 

You can choose not to do this now but after November 30, a password will be required.

To learn more about the new-look Pharma in Focus click here.


Subscribe
 
© 2003 - 2026 Lush Media | Privacy Statement | Subscribe to Pharma in Focus
home